Low circulating concentrations of citrulline and FGF19 predict chronic cholestasis and poor survival in adult patients with chronic intestinal failure: development of a Model for End-Stage Intestinal Failure (MESIF risk score)

Liver Inflammation Relates to Decreased Canalicular Bile Transporter Expression in Pediatric Onset Intestinal Failure

(2018) Annika Mutanen et al.   ANNALS OF SURGERY

Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure

(2018) Francisca Joly et al.   CLINICAL NUTRITION

Presentation of a nationwide multicenter registry of intestinal failure and intestinal transplantation

(2016) E.G. Neelis et al.   CLINICAL NUTRITION

ESPEN guidelines on chronic intestinal failure in adults

(2016) Loris Pironi et al.   CLINICAL NUTRITION

Altered systemic bile acid homeostasis contributes to liver disease in pediatric patients with intestinal failure

(2016) Yong-Tao Xiao et al.   Scientific Reports

Chronic cholestasis in patients on parenteral nutrition: the influence of restoring bowel continuity after mesenteric infarction

(2015) F Adaba et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2 -deficient mice

(2015) Mei Zhou et al.   HEPATOLOGY

Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure

(2015) Annika Mutanen et al.   JOURNAL OF HEPATOLOGY

Intestinal failure to produce FGF19: A culprit in intestinal failure–associated liver disease?

(2015) Karel J. van Erpecum et al.   JOURNAL OF HEPATOLOGY

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

(2015) Chiara Degirolamo et al.   NATURE REVIEWS DRUG DISCOVERY

Cost-effectiveness of intestinal transplantation for adult patients with intestinal failure: a simulation study

(2014) Anne Margot Roskott et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease

(2014) Prue M. Pereira-Fantini et al.   JOURNAL OF HEPATOLOGY

A nontumorigenic variant of FGF19 treats cholestatic liver diseases

(2014) J. Luo et al.   Science Translational Medicine

Phytosterols Promote Liver Injury and Kupffer Cell Activation in Parenteral Nutrition-Associated Liver Disease

(2013) K. C. El Kasmi et al.   Science Translational Medicine

Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome

(2012) Aurelien Amiot et al.   CLINICAL NUTRITION

Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis

(2011) Salvatore Modica et al.   GASTROENTEROLOGY

Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury

(2011) Karim C. El Kasmi et al.   HEPATOLOGY

Chronic biochemical cholestasis in patients receiving home parenteral nutrition: prevalence and predisposing factors

(2010) D. A. J. LLOYD et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation

(2010) L. Pironi et al.   GUT

The Receptor Tyrosine Kinase FGFR4 Negatively Regulates NF-kappaB Signaling

(2010) Kristine A. Drafahl et al.   PLoS One

High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis

(2008) Frank G. Schaap et al.   HEPATOLOGY